DW1198Z
Brachytherapy Head and Neck to None with Iridium 192 (Ir-192), High Dose Rate (HDR) Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | W Anatomical Regions |
| Operation | 1 Brachytherapy |
| Body Part | 1 Head and Neck |
| Approach | 9 High Dose Rate (HDR) |
| Device | 8 Iridium 192 (Ir-192) |
| Qualifier | Z None |
Procedure Overview
This family covers brachytherapy, the placement of sealed radioactive sources directly into or next to an anatomical region rather than into a single specifically classified organ. Small radioactive seeds, wires, or applicators are positioned so the radiation dose is concentrated close to the treatment area while sparing surrounding tissue more than external beam methods typically allow.
It's used for regional tumors or postoperative tumor beds where placing the source directly at the site gives better dose control, and sometimes for recurrent disease in a region previously treated with external radiation. The sources may be left temporarily or permanently depending on the isotope and clinical goal, and the procedure is performed by a radiation oncologist, often with imaging guidance to confirm correct placement.
Anatomy & Axis Detail
Head and Neck
Head and neck brachytherapy places radioactive sources into or near tumors of structures such as the oral cavity, oropharynx, tongue base, or nasopharynx, allowing a highly conformal boost dose to a site where surrounding organs at risk, including the spinal cord, salivary glands, and mandible, are densely packed within a small volume. Interstitial needles or intracavitary applicators are positioned directly into the tumor bed or a post-resection cavity, often as a boost following external beam therapy for squamous cell carcinoma. Because head and neck anatomy involves complex mucosal surfaces and swallowing structures, source placement is typically image-guided and coordinated with a multidisciplinary team, and documentation should specify the head and neck region as the body part when the target spans this composite anatomic area rather than a single named structure.
Modality Qualifier: High Dose Rate (HDR)
High Dose Rate (HDR) identifies brachytherapy delivered with a radioactive source of high activity, allowing treatment to be completed in minutes per fraction, often on an outpatient basis with afterloading applicators. It contrasts with Low Dose Rate (LDR), which uses a weaker source left in place for hours to days, trading a longer treatment time for a different radiobiological effect and staffing exposure profile.
Isotope: Iridium 192 (Ir-192)
Iridium-192 is a gamma-emitting radioisotope used almost exclusively for high-dose-rate or pulsed-dose-rate brachytherapy, delivered via remote afterloader through catheters or applicators placed in or near the tumor. It allows a shaped, temporary dose to sites like the cervix, prostate, or breast cavity, then the source is withdrawn rather than left implanted, distinguishing it from permanent seed isotopes such as I-125 or Pd-103.
Coding & Documentation
A code from this family requires documentation naming the anatomical region treated (rather than a specific organ with its own body system) along with the isotope or source type used and whether the implant is temporary or permanent, since these details determine the qualifier. Operative notes describing applicator or seed placement, along with dosimetry records, support the code choice. Coders most often err by coding to Anatomical Regions when the physician's note actually identifies a specific organ that has a dedicated body system, or by missing whether the source was left in place versus removed after treatment, which changes the qualifier selected.
Commonly Confused With
This is frequently confused with Brachytherapy coded to a named body system, such as Gynecological or Urinary, when the treated site is actually a specific organ; the distinguishing factor is whether the note names an organ (use that body system) or describes a regional field or postsurgical bed spanning tissue not tied to one organ (use Anatomical Regions). It also overlaps conceptually with Beam Radiation to the same region, but the presence of an implanted or applied source rather than an external delivery is what separates brachytherapy from beam therapy.